Dermatology Centre, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Manchester, U.K.
Br J Dermatol. 2014 Dec;171(6):1478-86. doi: 10.1111/bjd.13325. Epub 2014 Oct 26.
Low vitamin D status is prevalent in wintertime in populations at northerly latitudes. Photosensitive patients are advised to practise sun avoidance, but their sunlight exposure levels, photoprotective measures and resulting vitamin D status are unknown.
To examine seasonal vitamin D status in photosensitive patients relative to healthy individuals and to assess quantitatively behavioural and demographic contributors.
This was a longitudinal prospective cohort study (53·5°N) examining year-round 25-hydroxyvitamin D [25(OH)D] levels, sun-exposure behaviour and oral vitamin D intake in photosensitive patients diagnosed at a photoinvestigation unit (n = 53), compared with concurrently assessed healthy adults (n = 109).
Photosensitive patients achieved seasonal 25(OH)D variation, but insufficient (< 20 ng mL(-1); 50 nmol L(-1)) and even deficient (< 10 ng mL(-1); 25 nmol L(-1)) levels occurred at the summer peak in 47% and 9% of patients, respectively, rising to 73% and 32% at the winter trough. Adjusting for demographic factors, the mean values were lower than for healthy volunteers by 18% [95% confidence interval (CI) 4-29] in summer (P = 0·02) and 25% (95% CI 7-39) in winter (P = 0·01). Behavioural factors explained 25(OH)D differences between cohorts. Patients demonstrated lower weekend ultraviolet B doses (P < 0·001), smaller skin surface area exposure (P = 0·004) and greater sunscreen use (P < 0·001), while average oral vitamin D intake was low in both groups (photosensitive: 2·94 μg per day). Supplementation and summer surface area exposure predicted summer peak and winter trough 25(OH)D levels. A 1 μg per day increment in supplementary vitamin D raised summer and winter 25(OH)D by 5% (95% CI 3-7) and 9% (95% CI 5-12), respectively (both P < 0·001).
Photosensitive patients are, through their photoprotective measures, at high risk of year-round low vitamin D status. Guidance on oral measures should target this patient group and their physicians.
在高纬度地区的人群中,冬季维生素 D 水平普遍较低。建议光敏患者避免阳光照射,但他们的阳光暴露水平、光保护措施和由此产生的维生素 D 状况尚不清楚。
研究光敏患者相对于健康个体的季节性维生素 D 状况,并定量评估行为和人口统计学因素的影响。
这是一项在北纬 53.5°进行的纵向前瞻性队列研究,研究了 53 名在光诊断单位确诊的光敏患者和 109 名同期评估的健康成年人全年 25-羟维生素 D [25(OH)D] 水平、阳光暴露行为和口服维生素 D 摄入量。
光敏患者的 25(OH)D 水平呈现季节性变化,但在夏季高峰期,仍有 47%的患者维生素 D 水平不足(<20ng/mL;50nmol/L),9%的患者维生素 D 水平缺乏(<10ng/mL;25nmol/L),而在冬季低谷期,这一比例分别上升至 73%和 32%。调整人口统计学因素后,与健康志愿者相比,夏季时患者的平均水平低 18%(95%置信区间 4-29,P=0.02),冬季时低 25%(95%置信区间 7-39,P=0.01)。行为因素解释了队列间 25(OH)D 差异。与健康志愿者相比,患者的周末紫外线 B 剂量较低(P<0.001),皮肤暴露面积较小(P=0.004),防晒霜使用量较大(P<0.001),而两组的平均口服维生素 D 摄入量均较低(光敏患者:每天 2.94μg)。补充和夏季皮肤暴露面积可以预测夏季高峰和冬季低谷时的 25(OH)D 水平。每天增加 1μg 补充维生素 D 可使夏季和冬季的 25(OH)D 水平分别提高 5%(95%置信区间 3-7)和 9%(95%置信区间 5-12)(均 P<0.001)。
由于采取了光保护措施,光敏患者全年都有维生素 D 水平较低的高风险。应针对这一患者群体及其医生提供口服措施方面的指导。